According to Evofem Biosciences 's latest financial reports the company's current earnings (TTM) are -$17.85 M. In 2022 the company made an earning of -$84.13 M an increase over its 2021 earnings that were of -$0.17 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$17.85 M | -78.78% |
2022 | -$84.13 M | -49.57% |
2021 | -$0.17 B | 60.97% |
2020 | -$0.11 B | 96.47% |
2019 | -$52.75 M | -32.07% |
2018 | -$77.65 M | 242.02% |
2017 | -$22.71 M | 87.72% |
2016 | -$12.1 M | -71.22% |
2015 | -$42.03 M | 302.35% |
2014 | -$10.45 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.19 B | 932.77% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$18.95 M | 6.17% | ๐บ๐ธ USA |